Deka Closes USD $20 Million Series B2 Financing Led by MPM BioImpact
28 Sep 2023 //
PR NEWSWIRE
Deka Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)
05 Apr 2023 //
PR NEWSWIRE
Deka Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application
30 Jan 2023 //
PR NEWSWIRE